Literature DB >> 35460452

Paraneoplastic neurological syndrome: growing spectrum and relevance.

Valakunja Harikrishna Ganaraja1, Mohamed Rezk2, Divyanshu Dubey3.   

Abstract

Paraneoplastic neurological syndromes (PNSs) are group of disorders affecting one or multiple parts of the neuroaxis associated with underlying tumors. An antibody or autoantigen-specific cell-mediated immune response against neural antigen expressed in the tumor is the potential etiology for these rare but refractory disorders. In recent years, wide variety of neurological presentations and autoantibodies has been associated with paraneoplastic autoimmunity, leading to formulation of an updated expert consensus PNS diagnostic criteria. Recognition of these phenotypes and use of serological biomarkers may aid neurologists in early diagnosis of PNS cases encountered in the inpatient or outpatient practice. In this review article, we provide an overview of various clinical, radiological, and immunopathological characteristics of PNS. Furthermore, we discuss the updated PNS criteria and increasing recognition of neurological presentations resembling the PNS among patients receiving immune checkpoint inhibitors.
© 2022. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Immune checkpoint inhibitors; PNS criteria; Paraneoplastic neurological syndromes

Mesh:

Substances:

Year:  2022        PMID: 35460452     DOI: 10.1007/s10072-022-06083-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  73 in total

1.  Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients.

Authors:  F Graus; F Keime-Guibert; R Reñe; B Benyahia; T Ribalta; C Ascaso; G Escaramis; J Y Delattre
Journal:  Brain       Date:  2001-06       Impact factor: 13.501

Review 2.  Paraneoplastic syndromes involving the nervous system.

Authors:  Robert B Darnell; Jerome B Posner
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

Review 3.  Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo.

Authors:  José A Villadangos; Petra Schnorrer
Journal:  Nat Rev Immunol       Date:  2007-07       Impact factor: 53.106

4.  A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

Authors:  J P Ridge; F Di Rosa; P Matzinger
Journal:  Nature       Date:  1998-06-04       Impact factor: 49.962

5.  Immunofluorescent detection of antibodies against neurones in sensory carcinomatous neuropathy.

Authors:  P C Wilkinson; J Zeromski
Journal:  Brain       Date:  1965-09       Impact factor: 13.501

6.  Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers.

Authors:  Bruno Giometto; Wolfgang Grisold; Roberta Vitaliani; Francesc Graus; Jérôme Honnorat; Guido Bertolini
Journal:  Arch Neurol       Date:  2010-03

Review 7.  Neurologic Autoimmunity in the Era of Checkpoint Inhibitor Cancer Immunotherapy.

Authors:  Anastasia Zekeridou; Vanda A Lennon
Journal:  Mayo Clin Proc       Date:  2019-07-26       Impact factor: 7.616

8.  Encephalomyelitis with carcinoma.

Authors:  R A Henson; H L Hoffman; H Urich
Journal:  Brain       Date:  1965-09       Impact factor: 13.501

9.  CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity.

Authors:  Z Yu; T J Kryzer; G E Griesmann; K Kim; E E Benarroch; V A Lennon
Journal:  Ann Neurol       Date:  2001-02       Impact factor: 10.422

10.  "Hirnsymptome bei Carcinomatose" - Hermann Oppenheim and an Early Description of a Paraneoplastic Neurological Syndrome.

Authors:  Paulina Schulz; Harald Prüss
Journal:  J Hist Neurosci       Date:  2015-03-24       Impact factor: 0.529

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.